Board Member
Biomarin Pharmaceutical Inc (BMRN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Jean-Jacques Bienaimé is recorded as Board Member at Biomarin Pharmaceutical Inc (BMRN). Biomarin Pharmaceutical Inc reported in an 8-K filed November 3, 2023 that Jean-Jacques Bienaimé retired as President, Chairman and Chief Executive Officer, effective November 30, 2023. The proxy statement of Biomarin Pharmaceutical Inc reports total compensation of $21,976,020 for Jean-Jacques Bienaimé in fiscal 2023, including a base salary of $1,479,423. Disclosed compensation is on record for 7 fiscal years. Jean-Jacques Bienaimé has spoken on 6 earnings calls across 1 company, most recently for Biomarin Pharmaceutical Inc on November 1, 2023.
“Jean-Jacques Bienaimé will retire as the Company's President, Chairman and Chief Executive Officer effective as of close of business on November 30, 2023 (the "Retirement Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2023-05-23–present
Start not stated–2023-11-30
Start not stated–2023-11-30
Recorded roles and call appearances connecting this person to public companies.
Board Member
2023-05-23–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Biomarin Pharmaceutical Inc (BMRN) | Former CEO and Former Chairman of the Board | $1,479,423 | $21,976,020 |
| 2022 | Biomarin Pharmaceutical Inc (BMRN) | Former CEO and Former Chairman of the Board | $1,313,954 | $18,351,880 |
| 2021 | Biomarin Pharmaceutical Inc (BMRN) | Former CEO and Former Chairman of the Board | $1,260,000 | $18,262,538 |
| 2020 | Biomarin Pharmaceutical Inc (BMRN) | CEO | $1,298,846 | $18,146,399 |
| 2019 | Biomarin Pharmaceutical Inc (BMRN) | CEO | $1,200,385 | $18,405,856 |
| 2018 | Biomarin Pharmaceutical Inc (BMRN) | Chief Executive Officer | $1,149,423 | $15,627,893 |
| 2017 | Biomarin Pharmaceutical Inc (BMRN) | Chief Executive Officer | $1,094,423 | $15,916,985 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
